
Shingles vaccine may lower risk of stroke and heart failure
The story in brief
In an ongoing trial, over 160,000 people aged 65 and older in Denmark are receiving either Shingrix or no shingles vaccine. Early data suggests Shingrix may lower the risk of stroke, heart failure, and clogged arteries, though results are still being analyzed. The vaccine, which contains a protein from the varicella-zoster virus and a chemical called AS01, is also offered in the UK to those turning 65 on or after 1 September 2023.